These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30332430)

  • 1. Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer.
    Brown JC; Rhim AD; Manning SL; Brennan L; Mansour AI; Rustgi AK; Damjanov N; Troxel AB; Rickels MR; Ky B; Zemel BS; Courneya KS; Schmitz KH
    PLoS One; 2018; 13(10):e0204875. PubMed ID: 30332430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
    Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
    Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
    Rothé F; Maetens M; Rouas G; Paesmans M; Van den Eynde M; Van Laethem JL; Vergauwe P; Deboever G; Bareche Y; Vandeputte C; Ignatiadis M; Hendlisz A
    BMC Cancer; 2019 Apr; 19(1):304. PubMed ID: 30943928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial.
    Tay RY; Fernández-Gutiérrez F; Foy V; Burns K; Pierce J; Morris K; Priest L; Tugwood J; Ashcroft L; Lindsay CR; Faivre-Finn C; Dive C; Blackhall F
    Ann Oncol; 2019 Jul; 30(7):1114-1120. PubMed ID: 31020334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC).
    Melero JT; Ortega FG; Gonzalez AM; Carmona-Saez P; Garcia Puche JL; Sugarbaker PH; Delgado M; Lorente JA; Serrano MJ
    Surgery; 2016 Mar; 159(3):728-35. PubMed ID: 26518392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients.
    Li Y; Cheng X; Chen Z; Liu Y; Liu Z; Xu S
    Sci Rep; 2017 Jul; 7(1):4971. PubMed ID: 28694485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
    Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
    Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.
    Lu CY; Uen YH; Tsai HL; Chuang SC; Hou MF; Wu DC; Juo SH; Lin SR; Wang JY
    Br J Cancer; 2011 Mar; 104(7):1178-84. PubMed ID: 21343933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors.
    Brown JC; Damjanov N; Courneya KS; Troxel AB; Zemel BS; Rickels MR; Ky B; Rhim AD; Rustgi AK; Schmitz KH
    Psychooncology; 2018 Apr; 27(4):1221-1228. PubMed ID: 29388275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
    Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
    Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low number of detectable circulating tumor cells in non-metastatic colon cancer.
    Thorsteinsson M; Söletormos G; Jess P
    Anticancer Res; 2011 Feb; 31(2):613-7. PubMed ID: 21378346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
    Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
    Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
    Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
    Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
    Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS
    Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients.
    Mendelaar PAJ; Kraan J; Van M; Zeune LL; Terstappen LWMM; Oomen-de Hoop E; Martens JWM; Sleijfer S
    Mol Oncol; 2021 Jan; 15(1):116-125. PubMed ID: 32949099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
    Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
    Zhou J; Dong F; Cui F; Xu R; Tang X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.